Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose and Steady State Pharmacokinetics Study of 9cUAB30 in Healthy Volunteers.

Kolesar JM, Andrews S, Green H, Havighurst TC, Wollmer BW, DeShong K, Laux DE, Krontiras H, Muccio DD, Kim K, Grubbs CJ, House MG, Parnes HL, Heckman-Stoddard BM, Bailey HH.

Cancer Prev Res (Phila). 2019 Sep 4. pii: canprevres.0310.2019. doi: 10.1158/1940-6207.CAPR-19-0310. [Epub ahead of print]

PMID:
31484659
2.

Utility of CT Texture Analysis in Differentiating Low-Attenuation Renal Cell Carcinoma From Cysts: A Bi-Institutional Retrospective Study.

Kim NY, Lubner MG, Nystrom JT, Swietlik JF, Abel EJ, Havighurst TC, Silverman SG, McGahan JP, Pickhardt PJ.

AJR Am J Roentgenol. 2019 Aug 6:1-8. doi: 10.2214/AJR.19.21182. [Epub ahead of print]

PMID:
31386573
3.

Proproliferative function of adaptor protein GRB10 in prostate carcinoma.

Khan MI, Al Johani A, Hamid A, Ateeq B, Manzar N, Adhami VM, Lall RK, Rath S, Sechi M, Siddiqui IA, Choudhry H, Zamzami MA, Havighurst TC, Huang W, Ntambi JM, Mukhtar H.

FASEB J. 2019 Mar;33(3):3198-3211. doi: 10.1096/fj.201800265RR. Epub 2018 Oct 31.

PMID:
30379590
4.

Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers.

Scrima AT, Lubner MG, Abel EJ, Havighurst TC, Shapiro DD, Huang W, Pickhardt PJ.

Abdom Radiol (NY). 2019 Jun;44(6):1999-2008. doi: 10.1007/s00261-018-1649-2.

PMID:
29804215
5.

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Gee JR, Saltzstein DR, Kim K, Kolesar J, Huang W, Havighurst TC, Wollmer BW, Stublaski J, Downs T, Mukhtar H, House MG, Parnes HL, Bailey HH.

Cancer Prev Res (Phila). 2017 May;10(5):298-307. doi: 10.1158/1940-6207.CAPR-16-0167. Epub 2017 Mar 21.

6.

Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.

Brinkman AM, Chen G, Wang Y, Hedman CJ, Sherer NM, Havighurst TC, Gong S, Xu W.

Biomaterials. 2016 Sep;101:20-31. doi: 10.1016/j.biomaterials.2016.05.041. Epub 2016 May 27.

7.

Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.

Singh A, Singh A, Bauer SJ, Wheeler DL, Havighurst TC, Kim K, Verma AK.

Carcinogenesis. 2016 Jan;37(1):72-80. doi: 10.1093/carcin/bgv162. Epub 2015 Nov 19.

8.

Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Fabian CJ, Kimler BF, Zalles CM, Phillips TA, Metheny T, Petroff BK, Havighurst TC, Kim K, Bailey HH, Heckman-Stoddard BM.

Cancer Prev Res (Phila). 2015 Dec;8(12):1146-55. doi: 10.1158/1940-6207.CAPR-15-0109. Epub 2015 Sep 21.

9.

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH.

Eur J Cancer Prev. 2016 Jul;25(4):312-20. doi: 10.1097/CEJ.0000000000000189.

PMID:
26313229
10.

Intensity of physical activity in the energy expenditure of older adults.

Colbert LH, Matthews CE, Schoeller DA, Havighurst TC, Kim K.

J Aging Phys Act. 2014 Oct;22(4):571-7. doi: 10.1123/japa.2012-0257. Epub 2013 Dec 4.

11.

Predictors of willingness to participate in window-of-opportunity breast trials.

Wisinski KB, Faerber A, Wagner S, Havighurst TC, McElroy JA, Kim K, Bailey HH.

Clin Med Res. 2013 Sep;11(3):107-12. doi: 10.3121/cmr.2013.1136. Epub 2013 Apr 11.

12.

Comparative validity of physical activity measures in older adults.

Colbert LH, Matthews CE, Havighurst TC, Kim K, Schoeller DA.

Med Sci Sports Exerc. 2011 May;43(5):867-76. doi: 10.1249/MSS.0b013e3181fc7162.

13.

TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells.

Chen YW, Lee MS, Lucht A, Chou FP, Huang W, Havighurst TC, Kim K, Wang JK, Antalis TM, Johnson MD, Lin CY.

Am J Pathol. 2010 Jun;176(6):2986-96. doi: 10.2353/ajpath.2010.090665. Epub 2010 Apr 9.

14.

A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.

Bailey HH, Kim K, Verma AK, Sielaff K, Larson PO, Snow S, Lenaghan T, Viner JL, Douglas J, Dreckschmidt NE, Hamielec M, Pomplun M, Sharata HH, Puchalsky D, Berg ER, Havighurst TC, Carbone PP.

Cancer Prev Res (Phila). 2010 Jan;3(1):35-47. doi: 10.1158/1940-6207.CAPR-09-0096.

15.

Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Gee JR, Burmeister CB, Havighurst TC, Kim K.

Anticancer Res. 2009 Oct;29(10):3769-75.

16.

PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas.

Sand JM, Aziz MH, Dreckschmidt NE, Havighurst TC, Kim K, Oberley TD, Verma AK.

J Invest Dermatol. 2010 Jan;130(1):270-7. doi: 10.1038/jid.2009.212.

17.

Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors.

Adams WM, Kleiter MM, Thrall DE, Klauer JM, Forrest LJ, La Due TA, Havighurst TC.

Vet Radiol Ultrasound. 2009 May-Jun;50(3):330-5.

PMID:
19507402
18.

Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.

Hutson PR, Love RR, Havighurst TC, Rogers E, Cleary JF.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8722-7.

19.

Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer.

Love RR, Hutson PR, Havighurst TC, Cleary JF.

Clin Cancer Res. 2005 Feb 15;11(4):1500-3.

20.

Duration of signs and survival in premenopausal women with breast cancer.

Love RR, Duc NB, Baumann LC, Anh PT, To TV, Qian Z, Havighurst TC.

Breast Cancer Res Treat. 2004 Jul;86(2):117-24.

PMID:
15319564
21.

Dietary restriction and beta-cell sensitivity to glucose in adult male rhesus monkeys.

Gresl TA, Colman RJ, Havighurst TC, Allison DB, Schoeller DA, Kemnitz JW.

J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):598-610.

PMID:
12865475
22.

Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer.

Love RR, Astrow SH, Cheeks AM, Havighurst TC.

Breast Cancer Res Treat. 2003 Jun;79(3):329-34.

PMID:
12846417
23.

Insulin sensitivity and glucose effectiveness from three minimal models: effects of energy restriction and body fat in adult male rhesus monkeys.

Gresl TA, Colman RJ, Havighurst TC, Byerley LO, Allison DB, Schoeller DA, Kemnitz JW.

Am J Physiol Regul Integr Comp Physiol. 2003 Dec;285(6):R1340-54. Epub 2003 Jul 3.

24.

Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study.

Love RR, Ba Duc N, Cong Binh N, Mahler PA, Thomadsen BR, Hong Long N, Shen TZ, Havighurst TC.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):697-703.

PMID:
12788175
25.

Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer.

Love RR, Duc NB, Havighurst TC, Mohsin SK, Zhang Q, DeMets DL, Allred DC.

J Clin Oncol. 2003 Feb 1;21(3):453-7.

PMID:
12560434
26.

Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer.

Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh le D, Khang HX, Tran TL, Quy TT, Thuy NV, Thé PN, Cau TT, Tung ND, Huong DT, Quang le M, Hien NN, Thuong L, Shen TZ, Xin Y, Zhang Q, Havighurst TC, Yang YF, Hillner BE, DeMets DL.

J Clin Oncol. 2002 May 15;20(10):2559-66.

PMID:
12011136
27.

Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.

Love RR, Duc NB, Dinh NV, Shen TZ, Havighurst TC, Allred DC, DeMets DL.

J Natl Cancer Inst. 2002 May 1;94(9):662-9.

PMID:
11983754
28.

Young age as an adverse prognostic factor in premenopausal women with operable breast cancer.

Love RR, Duc NB, Dinh NV, Quy TT, Xin Y, Havighurst TC.

Clin Breast Cancer. 2002 Jan;2(4):294-8.

PMID:
11899361
29.

Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr.

Gresl TA, Colman RJ, Roecker EB, Havighurst TC, Huang Z, Allison DB, Bergman RN, Kemnitz JW.

Am J Physiol Endocrinol Metab. 2001 Oct;281(4):E757-65.

30.

Symptoms associated with oophorectomy and tamoxifen treatment for breast cancer in premenopausal Vietnamese women.

Love RR, Nguyen BD, Nguyen CB, Nguyen VD, Havighurst TC.

Breast Cancer Res Treat. 1999 Dec;58(3):281-6.

PMID:
10718489
31.

Delayed adjuvant tamoxifen in postmenopausal women with axillary node-negative breast cancer: mortality over 10 years.

Love RR, Olsen MR, Havighurst TC.

J Natl Cancer Inst. 1999 Jul 7;91(13):1167-8. No abstract available.

PMID:
10393732
32.

Correlation of serum L-carnitine and dehydro-epiandrosterone sulphate levels with age and sex in healthy adults.

Chiu KM, Schmidt MJ, Havighurst TC, Shug AL, Daynes RA, Keller ET, Gravenstein S.

Age Ageing. 1999 Mar;28(2):211-6.

PMID:
10350421
33.

Asthma in non-inner city Head Start children.

McGill KA, Sorkness CA, Ferguson-Page C, Gern JE, Havighurst TC, Knipfer B, Lemanske RF Jr, Busse WW.

Pediatrics. 1998 Jul;102(1 Pt 1):77-83.

PMID:
9651417
34.

Autoantibody testing for connective tissue diseases. Comparison of immunodiffusion, immunoblot, and enzyme immunoassay.

Bridges AJ, Lorden TE, Havighurst TC.

Am J Clin Pathol. 1997 Oct;108(4):406-10.

PMID:
9322593
35.

Adverse effects of low dose amiodarone: a meta-analysis.

Vorperian VR, Havighurst TC, Miller S, January CT.

J Am Coll Cardiol. 1997 Sep;30(3):791-8.

36.

Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers.

Wilk AI, Jensen NM, Havighurst TC.

J Gen Intern Med. 1997 May;12(5):274-83.

Supplemental Content

Loading ...
Support Center